Skip to main content
main-content

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Clinical Sarcoma Research 1/2017

Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy

Zeitschrift:
Clinical Sarcoma Research > Ausgabe 1/2017
Autoren:
K. Behi, M. Ayadi, E. Mezni, K. Meddeb, A. Mokrani, Y. Yahyaoui, F. Ksontini, H. Rais, N. Chrait, A. Mezlini

Abstract

Background

Cardiac tumors are a very rare entity. Leiomyosarcoma represents less than 1% of cases.

Case presentation

a 51-year-old woman diagnosed with primary left atrium leiomyosarcoma. She was treated by optimal surgery and adjuvant chemotherapy. She is still alive after a follow-up of 24 months without evidence of local or distant recurrence.

Conclusions

Cardiac leiomyosarcoma is a rare tumor with a dismal prognosis. Surgery is the mainstay of treatment. Adjuvant treatment is still controversial.
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2017

Clinical Sarcoma Research 1/2017 Zur Ausgabe

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise